【how to use niacin to pass a drug test】Sanofi to Withdraw Zantac After FDA Warns of Carcinogens-3 f s r 3 l a r 0 z t o u y w z m h k k g w q i r v 7 d p g

当前位置：首页 > Leisure > 【how to use niacin to pass a drug test】Sanofi to Withdraw Zantac After FDA Warns of Carcinogens 正文

【how to use niacin to pass a drug test】Sanofi to Withdraw Zantac After FDA Warns of Carcinogens

时间：2024-10-04 09:43:03 来源：3 f s r 3 l a r 0 z t o u y w z m h k k g w q i r v 7 d p g

Sanofi

SNY will have to withdraw its heartburn drug,how to use niacin to pass a drug test Zantac, from U.S. markets, following FDA’s request.

【how to use niacin to pass a drug test】Sanofi to Withdraw Zantac After FDA Warns of Carcinogens

The FDA has requested drugmakers marketing ranitidine, which is widely available by the brand name of Zantac, to immediately withdraw all prescription and OTC versions from the market. The FDA in its investigations observed that the ranitidine medications, which are approved for treating heartburn associated with acid indigestion, contain a carcinogenic contaminant, N-Nitrosodimethylamine ("NDMA").

【how to use niacin to pass a drug test】Sanofi to Withdraw Zantac After FDA Warns of Carcinogens

Please note that in October 2019 Sanofi initiated a voluntary recall of all Zantac over-the-counter (“OTC”) versions — Zantac 150, Zantac 150 Cool Mint, and Zantac 75 — in the United States. The decision was made by the company as a precautionary measure following a public statement from the FDA in September, alerting about a possible contamination of ranitidine medications.

【how to use niacin to pass a drug test】Sanofi to Withdraw Zantac After FDA Warns of Carcinogens

Due to recall of Zantac, Sanofi reported that sales of its Consumer Healthcare GBU declined 12.8% in the United States in the fourth quarter 2019. Complete withdrawal of the drug will further impact sales unfavorably in 2020. A few other generic drugmakers marketing ranitidine medications had also initiated voluntary recall of the drugs last year, including Perrigo PRGO and Lannett Company LCI.

Shares of Sanofi have lost 14.6% so far this year compared with the industry’s decrease of 11.1%.

Although low-levels of NDMA do not increase risk of cancer, the FDA has determined that NDMA in some ranitidine products increases with time and when medications are stored at higher than room temperatures. These can lead to consumer exposure to unacceptable levels of NDMA, which the agency states may cause cancer.

However, director of the FDA’s Center for Drug Evaluation and Research stated that though the agency had not observed unacceptable levels of NDMA in many of the samples that were tested, it was unsure of storage duration and conditions of the samples. Hence, as a precaution, the FDA decided that ranitidine medications should not be available to consumers and patients unless its quality can be assured.

With this withdrawal request, ranitidine medications will not be available for new or existing prescriptions or OTC use in the United States. The FDA has suggested alternative drugs for use, including famotidine (Pepcid), cimetidine (Tagamet), esomeprazole (AstraZeneca’s AZN Nexium), lansoprazole (Takeda Pharmaceuticals’ Prevacid) or omeprazole (Prilosec). These medications are not found to contain NDMA.

Story continues

Sanofi Price

Sanofi price | Sanofi Quote

Zacks Rank

Sanofi currently carries a Zacks Rank #3 (Hold). You can see

the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

Sanofi (SNY) : Free Stock Analysis Report

AstraZeneca PLC (AZN) : Free Stock Analysis Report

Perrigo Company plc (PRGO) : Free Stock Analysis Report

Lannett Co Inc (LCI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

View comments

Payments on mortgages to be suspended across Italy after coronavirus outbreak